SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-020194
Filing Date
2024-06-13
Accepted
2024-06-13 16:07:00
Documents
17
Period of Report
2024-06-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20240612_8k.htm   iXBRL 8-K 77516
2 EXHIBIT 3.1 ex_687496.htm EX-3.1 8664
3 EXHIBIT 10.1 ex_687497.htm EX-10.1 153433
4 EXHIBIT 10.2 ex_687498.htm EX-10.2 99139
  Complete submission text file 0001437749-24-020194.txt   537181

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20240611.xsd EX-101.SCH 3409
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20240611_def.xml EX-101.DEF 11804
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20240611_lab.xml EX-101.LAB 15848
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20240611_pre.xml EX-101.PRE 12019
20 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20240612_8k_htm.xml XML 2938
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 241041267
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)